The drugmaker Ely Lilly ( LLY -4.93%) has had a very successful run over the long run. Shares currently trade around $818 and are up 20,030% over the past 40 years. The stock has also performed well ...

New federal reports value a massive investment portfolio of stocks, bonds and mutual funds managed on behalf of The Church of ...

But for diabetes and obesity drugs like Ozempic and Zepbound, known as GLP-1s, cheaper copycats emerged almost ...

Vaccine makers hit hardest as Robert F. Kennedy Jr. appointment to Department of Health raises concerns for US drug market.

Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that ...

Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of Eli Lilly and (NYSE:LLY) with a Outperform ...

But earnings in the new range would still wind up being more than twice what the company registered for 2023. Shares of Indianapolis-based Eli Lilly and Co. were down 6%, or $57.02, to $846.56 in ...

The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain ...

Although CitiGroup denied wrongdoing both the company and the person suing agreed to a settlement of $29.5 million. The ...

About Features Building stronger businesses through community impact Nonprofit board service is a gift that also gives back ...

Essence may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.